Completed PHASE3 INTERVENTIONAL NCT00146016
Study on Chronic Hepatitis C Treatment With Interferon Alpha, Ribavirin and Amantadine in Naive Patients
Sponsor: UMC Utrecht
Conditions
Chronic Hepatitis C
Interventions
Amantadine
Updated 4 times since 2017 Last updated: Sep 1, 2005 Started: Feb 29, 2000 Completion: Jan 31, 2007
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This PHASE3 trial investigates Chronic Hepatitis C and is currently completed. UMC Utrecht leads this study, which shows 4 recorded versions since 2000 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
4 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Jan 2017 — Jan 2021 [monthly]
Completed PHASE3
First recorded
Feb 2000
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- UMC Utrecht
Data source: UMC Utrecht
For direct contact, visit the study record on ClinicalTrials.gov .